# Biorest Liposomal Alendronate With Stenting sTudy (BLAST)

> **NCT00739466** · PHASE2 · COMPLETED · sponsor: **BIOrest Ltd.** · enrollment: 226 (actual)

## Conditions studied

- Coronary Artery Stenosis

## Interventions

- **DRUG:** Liposomal Alendronate
- **DRUG:** Liposomal Alendronate
- **DRUG:** Saline infusion (placebo)

## Key facts

- **NCT ID:** NCT00739466
- **Lead sponsor:** BIOrest Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2016-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739466, "Biorest Liposomal Alendronate With Stenting sTudy (BLAST)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00739466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*